Northern Trust
IMRX icon

Northern Trust’s Immuneering IMRX Stock Holding History

Northern Trust’s Portfolio IMRX Stock Details IMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.18M Buy
436,992
+319,326
+271% +$1.62M ﹤0.01% 3085
2026
Q1 		$620K Buy
117,666
+8,605
+8% +$44.1K ﹤0.01% 3526
2025
Q4 		$718K Buy
109,061
+17,021
+18% +$109K ﹤0.01% 3520
2025
Q3 		$644K Buy
92,040
+52,311
+132% +$271K ﹤0.01% 3564
2025
Q2 		$134K Hold
39,729
– – ﹤0.01% 4041
2025
Q1 		$60.4K Hold
39,729
– – ﹤0.01% 4204
2024
Q4 		$87.4K Hold
39,729
– – ﹤0.01% 4180
2024
Q3 		$98.9K Sell
39,729
-119,188
-75% -$173K ﹤0.01% 4059
2024
Q2 		$203K Sell
158,917
-17,088
-10% -$28.1K ﹤0.01% 3863
2024
Q1 		$509K Sell
176,005
-7,922
-4% -$44.4K ﹤0.01% 3560
2023
Q4 		$1.35M Sell
183,927
-1,531
-0.8% -$10.2K ﹤0.01% 3190
2023
Q3 		$1.42M Buy
185,458
+12,237
+7% +$112K ﹤0.01% 3117
2023
Q2 		$1.76M Buy
173,221
+135,921
+364% +$1.31M ﹤0.01% 3078
2023
Q1 		$362K Buy
37,300
+2,640
+8% +$15K ﹤0.01% 3587
2022
Q4 		$168K Hold
34,660
– – ﹤0.01% 3941
2022
Q3 		$496K Buy
34,660
+18,977
+121% +$151K ﹤0.01% 3511
2022
Q2 		$85K Sell
15,683
-127,875
-89% -$682K ﹤0.01% 4232
2022
Q1 		$929K Buy
143,558
+67,667
+89% +$650K ﹤0.01% 3450
2021
Q4 		$1.23M Buy
75,891
+3,279
+5% +$79.8K ﹤0.01% 3462
2021
Q3 		$1.93M Buy
+72,612
New +$1.95M ﹤0.01% 3309

Other funds holding IMRX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DA
DCF Advisers Greenwich, Connecticut $566M AUM 197.74% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return

Northern Trust's IMRX Position: Q2 2026 in Review

Northern Trust increased its Immuneering (IMRX) stake by 271% in Q2 2026, buying an estimated $1.62M and bringing the position to 436,992 shares worth $2.18M. The position accounts for ﹤0.01% of the portfolio, ranked #3085.

Northern Trust first reported a position in IMRX in Q3 2021 and has held it in 20 quarters since. 112 funds tracked by Wall St. Rank hold IMRX as of Q2 2026.

  • Northern Trust held 436,992 shares of Immuneering worth $2.18M as of Q2 2026.
  • Northern Trust bought 319,326 Immuneering shares in Q2 2026, an estimated $1.62M.
  • Immuneering made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #3085 holding.
  • Northern Trust first reported a position in Immuneering in Q3 2021 and has held it in 20 quarters since.
  • 112 funds tracked by Wall St. Rank held Immuneering as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.